Product Description for Glucagon
Rabbit anti Mammalia Glucagon.
Presentation: Serum
Product is tested for Frozen Sections, Immunocytochemistry/Immunofluorescence, Paraffin Sections.
Presentation: Serum
Product is tested for Frozen Sections, Immunocytochemistry/Immunofluorescence, Paraffin Sections.
Properties for Glucagon
| Product Category | Primary Antibodies |
|---|---|
| Quantity | 0.1 ml |
| Synonyms | GCG |
| Presentation | Serum |
| Reactivity | Mam |
| Applications | C, ICC/IF, P |
| Clonality | Polyclonal |
| Host | Rabbit |
| Shipping to | Worldwide |
| PDF datasheet | View Datasheet |
| Manufacturer | ImmunoStar Inc. |
Datasheet Extract
| Immunogen |
|
|---|---|
| Format |
|
| Gene ID | 2641 |
Accessory Products
Proteins and/or Positive Controls
Proteins for Glucagon (29 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| AR10218PU-L |
GLP1 (7-36) |
||||||
|
Human | Purified | > 95.0% as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10218PU-N |
GLP1 (7-36) |
||||||
|
Human | Purified | > 95.0% as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10218PU-S |
GLP1 (7-36) |
||||||
|
Human | Purified | > 95.0% as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10220PU-L |
GLP1 |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | Synthetic | |||
| OriGene Technologies GmbH | |||||||
| AR10220PU-N |
GLP1 |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | Synthetic | |||
| OriGene Technologies GmbH | |||||||
| AR10220PU-S |
GLP1 |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | Synthetic | |||
| OriGene Technologies GmbH | |||||||
| PA1186 |
GLP1 (7-36) |
||||||
|
Human | Purified |
> 95 % Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA1186X |
GLP1 (7-36) |
||||||
|
Human | Purified |
> 95 % Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA1186XC |
GLP1 (7-36) |
||||||
|
Human | Purified |
> 95 % Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR00066PU-N |
GLP2 |
||||||
|
Human | Purified | >95% pure (HPLC) | Synthetic | |||
| OriGene Technologies GmbH | |||||||
| TP302717 |
Glucagon |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP720706 |
Glucagon |
||||||
|
Human |
> 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
10 µg /
€299.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP723140 |
Glucagon |
||||||
|
Human |
> 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
0.2 mg /
€135.00
|
|||
| OriGene Technologies, Inc. | |||||||
| AR10219PU-L |
Glucagon (53-81) |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | Synthetic | |||
| OriGene Technologies GmbH | |||||||
| AR10219PU-N |
Glucagon (53-81) |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | Synthetic | |||
| OriGene Technologies GmbH | |||||||
| AR10219PU-S |
Glucagon (53-81) |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | Synthetic | |||
| OriGene Technologies GmbH | |||||||
| AR10221PU-L |
Glucagon (53-81) |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10221PU-N |
Glucagon (53-81) |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10221PU-S |
Glucagon (53-81) |
||||||
|
Human | Purified | > 98.0% as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR39079PU-L |
Glucagon (90-180, His-tag) |
||||||
|
Human | Purified | > 95 % | E. coli |
0.5 mg /
€820.00
|
||
| OriGene Technologies GmbH | |||||||
| AR39079PU-N |
Glucagon (90-180, His-tag) |
||||||
|
Human | Purified | > 95 % | E. coli |
0.1 mg /
€320.00
|
||
| OriGene Technologies GmbH | |||||||
| PA1187 |
Glucagon |
||||||
|
Human | Purified |
> 98 % pure as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA1187X |
Glucagon |
||||||
|
Human | Purified |
> 98 % pure as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA1187XC |
Glucagon |
||||||
|
Human | Purified |
> 98 % pure as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| H00002641-P01-10 |
Glucagon |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00002641-P01-25 |
Glucagon |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| AR10224PU-L |
Oxyntomodulin / OXM |
||||||
|
Human | Purified | >90.0% pure as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10224PU-N |
Oxyntomodulin / OXM |
||||||
|
Human | Purified | >90.0% pure as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10224PU-S |
Oxyntomodulin / OXM |
||||||
|
Human | Purified | >90.0% pure as determined by both RP-HPLC and SDS-PAGE analysis | E. coli | |||
| OriGene Technologies GmbH | |||||||
Positive controls for Glucagon (2 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| LY419562 |
GCG overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| NBL1-11005 |
Glucagon Lysate |
||||||
![]() |
|||||||
| Novus Biologicals Inc. | |||||||
Recommended Secondary Antibodies for Glucagon (9 products)
| Catalog No. | Host | Clone/Iso. | Pres. | React. | Applications | ||
|---|---|---|---|---|---|---|---|
| R1364AP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | AP | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364B |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | Biotin | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364F |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | FITC | Rb | E, ICC/IF, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364HRP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | HRP | Rb | E, P, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364T |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | TRITC | Rb | E, F, ICC/IF | |||
| OriGene Technologies GmbH | |||||||
| R1427R |
Rabbit IgG F(ab)2 Fragment (H+L chain) antibody |
||||||
|
Donkey | PE | Rb | F | |||
| OriGene Technologies GmbH | |||||||
| R1458C2 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy2 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C3 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy3 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C5 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy5 | |||||
| OriGene Technologies GmbH | |||||||
![Western Blot: Glucagon Lysate [NBL1-11005] - Western Blot experiments.
Left-Control; Right -Over-expression Lysate for GCG](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/Novus/Glucagon%20Lysate-Western%20Blot-NBL1-11005-img0001.jpg)
